Literature DB >> 11575928

Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.

R Lang1, A Kocourek, M Braun, H Tschesche, R Huber, W Bode, K Maskos.   

Abstract

The macrophage elastase enzyme (MMP-12) expressed mainly in alveolar macrophages has been identified in the mouse lung as the main destructive agent associated with cigarette smoking, which gives rise to emphysema, both directly via elastin degradation and indirectly by disturbing the proteinase/antiproteinase balance via inactivation of the alpha1-proteinase inhibitor (alpha1-PI), the antagonist of the leukocyte elastase. The catalytic domain of human recombinant MMP-12 has been crystallized in complex with the broad-specificity inhibitor batimastat (BB-94). The crystal structure analysis of this complex, determined using X-ray data to 1.1 A and refined to an R-value of 0.165, reveals an overall fold similar to that of other MMPs. However, the S-shaped double loop connecting strands III and IV is fixed closer to the beta-sheet and projects its His172 side-chain further into the rather hydrophobic active-site cleft, defining the S3 and the S1-pockets and separating them from each other to a larger extent than is observed in other MMPs. The S2-site is planar, while the characteristic S1'-subsite is a continuous tube rather than a pocket, in which the MMP-12-specific Thr215 replaces a Val residue otherwise highly conserved in almost all other MMPs. This alteration might allow MMP-12 to accept P1' Arg residues, making it unique among MMPs. The active-site cleft of MMP-12 is well equipped to bind and efficiently cleave the AlaMetPhe-LeuGluAla sequence in the reactive-site loop of alpha1-PI, as occurs experimentally. Similarities in contouring and particularly a common surface hydrophobicity both inside and distant from the active-site cleft explain why MMP-12 shares many substrates with matrilysin (MMP-7). The MMP-12 structure is an excellent template for the structure-based design of specific inhibitors for emphysema therapy and for the construction of mutants to clarify the role of this MMP. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575928     DOI: 10.1006/jmbi.2001.4954

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

2.  Modified AutoDock for accurate docking of protein kinase inhibitors.

Authors:  Oleksandr V Buzko; Anthony C Bishop; Kevan M Shokat
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

3.  Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3.

Authors:  Xiangyang Liang; A Arunima; Yingchu Zhao; Rajagopalan Bhaskaran; Anuradha Shende; Todd S Byrne; Jeremy Fleeks; Mark O Palmier; Steven R Van Doren
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

Review 4.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

5.  Conformational variability of matrix metalloproteinases: beyond a single 3D structure.

Authors:  Ivano Bertini; Vito Calderone; Marta Cosenza; Marco Fragai; Yong-Min Lee; Claudio Luchinat; Stefano Mangani; Beatrice Terni; Paola Turano
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

6.  Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.

Authors:  Seakwoo Lee; Hyun I Park; Qing-Xiang Amy Sang
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

7.  Global gene expression profile progression in Gaucher disease mouse models.

Authors:  You-Hai Xu; Li Jia; Brian Quinn; Matthew Zamzow; Keith Stringer; Bruce Aronow; Ying Sun; Wujuan Zhang; Kenneth D R Setchell; Gregory A Grabowski
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969

8.  Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Nusayba A Bagegni; Xiangyang Liang; Steven R Van Doren
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

9.  Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.

Authors:  Markus-N Kruse; Christoph Becker; Daniel Lottaz; Danny Köhler; Irene Yiallouros; Hans-Willi Krell; Erwin E Sterchi; Walter Stöcker
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme.

Authors:  Eduardo E Chufán; Mithu De; Betty A Eipper; Richard E Mains; L Mario Amzel
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.